BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31519557)

  • 1. Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis.
    Buentzel J; Heinz J; Bleckmann A; Bauer C; Röver C; Bohnenberger H; Saha S; Hinterthaner M; Baraki H; Kutschka I; Emmert A
    Anticancer Res; 2019 Sep; 39(9):4603-4612. PubMed ID: 31519557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
    Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
    Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
    Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
    Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
    Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
    Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis.
    Jensen S; Bloch Z; Quist M; Hansen TTD; Johansen C; Pappot H; Suetta C; Skjødt Rafn B
    Acta Oncol; 2023 Mar; 62(3):318-328. PubMed ID: 37051865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia impairs prognosis of patients with liver cirrhosis.
    Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
    Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.
    Tsukioka T; Izumi N; Mizuguchi S; Kyukwang C; Komatsu H; Toda M; Hara K; Miyamoto H; Nishiyama N
    Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):716-722. PubMed ID: 30105630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.
    Kim EY; Lee HY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28426181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.
    Fang P; Zhou J; Xiao X; Yang Y; Luan S; Liang Z; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):3-16. PubMed ID: 36415154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis.
    Komici K; Dello Iacono A; De Luca A; Perrotta F; Bencivenga L; Rengo G; Rocca A; Guerra G
    Front Endocrinol (Lausanne); 2021; 12():576619. PubMed ID: 33935962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis.
    Deng HY; Hou L; Zha P; Huang KL; Peng L
    Eur J Surg Oncol; 2019 May; 45(5):728-735. PubMed ID: 30348603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.
    van Vugt JL; Levolger S; de Bruin RW; van Rosmalen J; Metselaar HJ; IJzermans JN
    Am J Transplant; 2016 Aug; 16(8):2277-92. PubMed ID: 26813115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
    Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
    Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer: Analysis from a Large-Scale Cohort.
    Zhuang CL; Huang DD; Pang WY; Zhou CJ; Wang SL; Lou N; Ma LL; Yu Z; Shen X
    Medicine (Baltimore); 2016 Mar; 95(13):e3164. PubMed ID: 27043677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia and sarcopenic obesity.
    Choi KM
    Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.